Cosentyx® (secukinumab)
for Psoriasis

Cosentyx (secukinumab) is an immunosuppressant used to treat autoimmune conditions like plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, enthesitis-related arthritis, hidradenitis suppurativa (HS), and non-radiographic axial spondyloarthritis. It works by inhibiting the activity of IL-17A, a protein involved in inflammation. Cosentyx is a monoclonal antibody classified as an interleukin (IL) inhibitor.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Psoriasis